FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285683992> ?p ?o ?g. }

• W4285683992 endingPage "137" @default.
• W4285683992 startingPage "125" @default.
• W4285683992 abstract "The present study intends to investigate COVID-19 by targeting their main proteins with 17 selected drugs used for treating Oral Lichen Planus (OLP) which is a chronic muco-cutaneous disorder. Here, an attempt is made to gain better insight into the structure of various drugs targeting specific proteins which will be helpful in developing drugs useful for therapeutic and preventive measures.In silico studies, molecular docking and molecular dynamic simulations were performed to repurpose the therapeutic drugs (n = 17) which were used to treat OLP against COVID-19. In addition, the maximum binding affinities of the key protein spike glycoprotein, main-protease (Mpro) of coronavirus, and Angiotensin-Converting Enzyme-2 (ACE-2) in the human body were evaluated with the selected drugs.Epigallocatechin-3-gallate (EGCG) showed the highest docking values among the drugs selected for repurposing. Among the target proteins, EGCG has shown maximum binding affinity with ACE-2 receptor. Further, according to the molecular dynamic simulation studies, EGCG has shown the least conformational fluctuations with Mpro.EGCG can be a potential inhibitor drug which can bind with ACE-2 receptor thus inhibiting the interaction of mainly Mpro protein and spike glycoprotein of SARS-CoV-2.EGCG, a natural compound shows antiviral potential having considerably high affinity and stability with SARS-CoV-2. It might be further employed as a lead drug against selective inhibitors of SARS-CoV-2 for the therapeutic management of COVID-19 patients after necessary clinical trials." @default.
• W4285683992 created "2022-07-17" @default.
• W4285683992 creator A5014874094 @default.
• W4285683992 creator A5016055875 @default.
• W4285683992 creator A5037938008 @default.
• W4285683992 creator A5056916167 @default.
• W4285683992 creator A5064431188 @default.
• W4285683992 creator A5071883540 @default.
• W4285683992 creator A5082789399 @default.
• W4285683992 creator A5089862503 @default.
• W4285683992 date "2022-04-29" @default.
• W4285683992 modified "2023-10-01" @default.
• W4285683992 title "Lichen planus drugs re-purposing as potential anti COVID-19 therapeutics through molecular docking and molecular dynamics simulation approach." @default.
• W4285683992 cites W1808332509 @default.
• W4285683992 cites W2000040025 @default.
• W4285683992 cites W2001575911 @default.
• W4285683992 cites W2017767848 @default.
• W4285683992 cites W2018682845 @default.
• W4285683992 cites W2031168104 @default.
• W4285683992 cites W2040385059 @default.
• W4285683992 cites W2050267968 @default.
• W4285683992 cites W2079953901 @default.
• W4285683992 cites W2098719131 @default.
• W4285683992 cites W2102377211 @default.
• W4285683992 cites W2136581630 @default.
• W4285683992 cites W2735481121 @default.
• W4285683992 cites W2919429227 @default.
• W4285683992 cites W3010377921 @default.
• W4285683992 cites W3013500709 @default.
• W4285683992 cites W3013953493 @default.
• W4285683992 cites W3014571869 @default.
• W4285683992 cites W3026512259 @default.
• W4285683992 cites W3032158517 @default.
• W4285683992 cites W3116606491 @default.
• W4285683992 cites W3125686621 @default.
• W4285683992 cites W3131126143 @default.
• W4285683992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35382132" @default.
• W4285683992 hasPublicationYear "2022" @default.
• W4285683992 type Work @default.
• W4285683992 citedByCount "1" @default.
• W4285683992 countsByYear W42856839922023 @default.
• W4285683992 crossrefType "journal-article" @default.
• W4285683992 hasAuthorship W4285683992A5014874094 @default.
• W4285683992 hasAuthorship W4285683992A5016055875 @default.
• W4285683992 hasAuthorship W4285683992A5037938008 @default.
• W4285683992 hasAuthorship W4285683992A5056916167 @default.
• W4285683992 hasAuthorship W4285683992A5064431188 @default.
• W4285683992 hasAuthorship W4285683992A5071883540 @default.
• W4285683992 hasAuthorship W4285683992A5082789399 @default.
• W4285683992 hasAuthorship W4285683992A5089862503 @default.
• W4285683992 hasConcept C103637391 @default.
• W4285683992 hasConcept C104317684 @default.
• W4285683992 hasConcept C142724271 @default.
• W4285683992 hasConcept C159110408 @default.
• W4285683992 hasConcept C181199279 @default.
• W4285683992 hasConcept C185592680 @default.
• W4285683992 hasConcept C18903297 @default.
• W4285683992 hasConcept C2775905019 @default.
• W4285683992 hasConcept C2776714187 @default.
• W4285683992 hasConcept C2779134260 @default.
• W4285683992 hasConcept C2780035454 @default.
• W4285683992 hasConcept C3007834351 @default.
• W4285683992 hasConcept C3008058167 @default.
• W4285683992 hasConcept C41685203 @default.
• W4285683992 hasConcept C519536355 @default.
• W4285683992 hasConcept C524204448 @default.
• W4285683992 hasConcept C55493867 @default.
• W4285683992 hasConcept C70721500 @default.
• W4285683992 hasConcept C71924100 @default.
• W4285683992 hasConcept C74187038 @default.
• W4285683992 hasConcept C86803240 @default.
• W4285683992 hasConcept C98274493 @default.
• W4285683992 hasConceptScore W4285683992C103637391 @default.
• W4285683992 hasConceptScore W4285683992C104317684 @default.
• W4285683992 hasConceptScore W4285683992C142724271 @default.
• W4285683992 hasConceptScore W4285683992C159110408 @default.
• W4285683992 hasConceptScore W4285683992C181199279 @default.
• W4285683992 hasConceptScore W4285683992C185592680 @default.
• W4285683992 hasConceptScore W4285683992C18903297 @default.
• W4285683992 hasConceptScore W4285683992C2775905019 @default.
• W4285683992 hasConceptScore W4285683992C2776714187 @default.
• W4285683992 hasConceptScore W4285683992C2779134260 @default.
• W4285683992 hasConceptScore W4285683992C2780035454 @default.
• W4285683992 hasConceptScore W4285683992C3007834351 @default.
• W4285683992 hasConceptScore W4285683992C3008058167 @default.
• W4285683992 hasConceptScore W4285683992C41685203 @default.
• W4285683992 hasConceptScore W4285683992C519536355 @default.
• W4285683992 hasConceptScore W4285683992C524204448 @default.
• W4285683992 hasConceptScore W4285683992C55493867 @default.
• W4285683992 hasConceptScore W4285683992C70721500 @default.
• W4285683992 hasConceptScore W4285683992C71924100 @default.
• W4285683992 hasConceptScore W4285683992C74187038 @default.
• W4285683992 hasConceptScore W4285683992C86803240 @default.
• W4285683992 hasConceptScore W4285683992C98274493 @default.
• W4285683992 hasIssue "2" @default.
• W4285683992 hasLocation W42856839921 @default.
• W4285683992 hasOpenAccess W4285683992 @default.
• W4285683992 hasPrimaryLocation W42856839921 @default.

• next